These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Selective estrogen receptor modulators as a new concept in preventing health risks of menopause]. Vokrouhlická J; Pavo I; Stĕpán J Cas Lek Cesk; 1998 Nov; 137(22):679-85. PubMed ID: 9929934 [TBL] [Abstract][Full Text] [Related]
4. [Selected estrogen receptor modulators--new possibilities in prevention and therapy of osteoporosis?]. Dören M Med Klin (Munich); 1996 Feb; 91 Suppl 1():44-5. PubMed ID: 8839116 [No Abstract] [Full Text] [Related]
5. Raloxifene: a selective estrogen receptor modulator. Scott JA; Da Camara CC; Early JE Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743 [TBL] [Abstract][Full Text] [Related]
6. A new alternative to estrogen: raloxifene. Runowicz C Health News; 1998 Jun; 4(8):4. PubMed ID: 9644506 [No Abstract] [Full Text] [Related]
7. Emerging therapies for the prevention or treatment of postmenopausal osteoporosis. Sato M; Grese TA; Dodge JA; Bryant HU; Turner CH J Med Chem; 1999 Jan; 42(1):1-24. PubMed ID: 9888829 [No Abstract] [Full Text] [Related]
8. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Fitzpatrick LA Mayo Clin Proc; 1999 Jun; 74(6):601-7. PubMed ID: 10377937 [TBL] [Abstract][Full Text] [Related]
9. [Raloxifene: a selective modulator of estrogen receptors]. van den Brûle FA; Kalbus MF; Gaspard UJ J Gynecol Obstet Biol Reprod (Paris); 1999 Dec; 28(8):788-99. PubMed ID: 10635481 [TBL] [Abstract][Full Text] [Related]
10. Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health. Goldstein SR Int J Fertil Womens Med; 1999; 44(5):221-6. PubMed ID: 10569450 [TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators and postmenopausal women's health: the promise for the next millennium. Agnusdei D Aging (Milano); 1998 Aug; 10(4):269-72. PubMed ID: 9825017 [No Abstract] [Full Text] [Related]
12. Raloxifene. Gass ML South Med J; 1999 Nov; 92(11):1120-3. PubMed ID: 10586846 [No Abstract] [Full Text] [Related]
13. Clinical efficacy of SERMs. Dere WH Aging (Milano); 1998 Apr; 10(2):160-1. PubMed ID: 9666217 [No Abstract] [Full Text] [Related]
15. Quantitative assessment of bone mineral density during estrogen replacement therapy. Thijssen JH; Druckmann R Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():29-34. PubMed ID: 10862266 [No Abstract] [Full Text] [Related]
16. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease]. Kozakiewicz K; Wycisk A Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486 [TBL] [Abstract][Full Text] [Related]
17. [Selective estrogen receptor modulators (SERMs) in the practice]. Nagykálnai T Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896 [TBL] [Abstract][Full Text] [Related]
18. Next generation of SERMs being seen in clinic. Smigel K J Natl Cancer Inst; 1997 Jul; 89(13):913. PubMed ID: 9214669 [No Abstract] [Full Text] [Related]
19. Raloxifene for postmenopausal osteoporosis. Med Lett Drugs Ther; 1998 Mar; 40(1022):29-30. PubMed ID: 9529516 [No Abstract] [Full Text] [Related]
20. Prevention and treatment of osteoporosis: where are we today? Maby JI J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S9-12. PubMed ID: 12625633 [No Abstract] [Full Text] [Related] [Next] [New Search]